Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5722393-(1-hydroxydecylidene)-5-(2-hydroxyethyl)pyrrolidine-2,4-dioneMeSH

  has antibacterial activity; structure in first source

• C5875173-(1-oxo-2-hydrazino-3-(p-toluenesulfon))quinoloneMeSH

  structure in first source

• C5611063-(12-hydroxymethyl-1,12 dicarba-closo-dodecaboran-1-yl)benzonitrileMeSH

  structure in first source

• C5766303-(1H-1,2,3-triazol-1-yl)dihydrofuran-2(3H)-oneMeSH

  structure in first source

• C5602423-(1H-benzo(d)(1,2,3)triazol-1-yl)-1-oxo-1-m-tolylpropan-2-yl-nicotinateMeSH

  structure in first source

• C5721893-(1H-indazol-5-yl)-N-propylimidazo(1,2-b)pyridazin-6-amineMeSH

  a haspir inhibitor with antineoplastic activity; structure in first source

• C5844853-(1H-indol-3-yl)pyrrolidine-2,5-dioneMeSH

  structure in first source

• C5681613-(2'-fluoro-6',7'-dihydrospiro(piperidine-4,4'-thieno(3,2-c)pyran)-1-yl)-2-(2-fluorobenzyl)-N-methylpropanamideMeSH

  a nociceptin/orphanin FQ peptide receptor ligand

• C5602033-(2,3-dihydroxy-4-methoxyphenyl)-8-(3,7-dimethylocta-2,6-dienyl)-5,7-dihydroxy-2,3-dihydrochromen-4-oneMeSH

  antibacterial isolated from Dalbergia pervillei; structure in first source

• C5786833-(2,4-dimethylphenyl)-2-methylquinazolin-4(3H)-oneMeSH

  structure in first source

• C5789043-(2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)propanoic acidMeSH

  from Xuezhikang capsule; structure in first source

• C5768103-(2,8,9-trioxa-5-aza-1-germatricyclo(3.3.3.0)undecane-1-yl)-3-(4-hydroxyl-3-methoxyphenyl)propionic acidMeSH

  has antineoplastic activity; structure in first source

• C5779673-(2-((cyclobutylmethyl)(phenethyl)amino)ethyl)phenolMeSH

  structure in first source

• C5604513-(2-(1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl)propyl hydrogen sulfateMeSH

  has antibacterial activity; structure in first source

• C5811413-(2-(3,4-dehydropyrrolinyl)methoxy)-5-(3'-fluoropropyl)pyridineMeSH

  for PET imaging of alpha2beta4 nicotinic receptors; structure in first source

• C5712813-(2-(3-(morpholinomethyl)phenyl)thieno(3,2-b)pyridin-7-ylamino)phenolMeSH

  inhibits discoidin domain receptor family tyrosine kinases; structure in first source

• C5868383-(2-(3-fluorophenyl)-2-oxoethylidene)-2,3,6,7-tetrahydro-1H-pyrazino(2,1-a)isoquinolin-4(11bH)-oneMeSH

  an antioxidant response element activator; structure in first source

• C5875973-(2-(4-fluorobenzyl)imidazo(2,1-beta)(1),(3)thiazol-6-yl)-2H-chromen-2-oneMeSH

  a midkine inhibitor; structure in first source

• C5806023-(2-(4-hydroxyphenyl)-2-oxoethyl)-5,6-dihydropyridin-2(1H)-oneMeSH

  from cultures of thermophilic soil fungus Humicola grisea var thermoidea; structure in first source

• C5811833-(2-(4-isopropylpiperazin-1-yl)-2-oxoethyl)-6-(4-methoxybenzoyl)benzo(d)thiazol-2(3H)-oneMeSH

  structure in first source

• C5807083-(2-(4-methoxyphenyl)imidazo(2,1-b)(1,3,4)thiadiazol-6-yl)anilineMeSH

  structure in first source

• C5696413-(2-(5-(2-pyridin-4-ylvinyl)pyridin-3-yl)vinyl)anilineMeSH

  a neuroprotective agent; structure in first source

• C5610513-(2-(dimethylamino)ethylamino)-N-(4,9-dioxo-4,9-dihydronaphtho(2,3-b)thiophen-3-yl)propanamideMeSH

  has antineoplastic activity; structure in first source

• C5609053-(2-(dimethylamino)isopropoxy)-1-hydroxybenzo(b)naphtho(2,3-d)furan-6,11-dioneMeSH

  has antineoplastic activity; structure in first source

• C5765803-(2-acetyl-1H-pyrrol-1-yl)-5-(prop-2-yn-1-yl)dihydrofuran-2(3H)-oneMeSH

  from Dimocarpus longan Lour. seeds; structure in first source

• C5618603-(2-amino-6-(3-hydroxy-3,3-dimethylprop-1-yn-1-yl)pyrimidin-4-yl)-1,1-dimethylprop-2-yn-1-olMeSH

  structure in first source

• C5618613-(2-amino-6-chloropyrimidin-4-yl)-1,1-dimethylprop-2-yn-1-ol monohydrateMeSH

  structure in first source

• C5833133-(2-aminoethyl)-5-(3-(4-butoxylphenyl)propylidene)thiazolidine-2,4-dioneMeSH

  inhibits sphingosine kinase 2

• C5830103-(2-aminopropyl)indoleMeSH

  structure in first source

• C5711213-(2-azetidinylmethoxy)-5-(3'-fluoropropyl)pyridineMeSH

  a nicotinic alpha4beta2 receptor antagonist and imaging agent; structure in first source

• C5844693-(2-benzyloxyphenyl)-5-chloromethylisoxazoleMeSH

  activates cystic fibrosis transmembrane conductance regulator (CFTR); structure in first source

• C5779553-(2-chlorophenyl)-1-(2,4-dihydroxyphenyl)prop-2-en-1-oneMeSH

  structure in first source

• C5760573-(2-deoxypentofuranosyl)-5,6,7,8-tetrahydro-8-hydroxy-6-tridecylpyrimido(1,2-a)purine-10(3H)oneMeSH

  structure in first source

• C5795553-(2-dimethylaminomethylcyclohexyl)phenolMeSH

  has monoaminergic activity

• C5867493-(2-ethoxypropyl)-2-thioxo-2,3-dihydro-1H-purin-6(9H)-oneMeSH

  structure in first source

• C5735553-(2-fluoro-4-(((4'-((4-hydroxy-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)methoxy)-2',6'-dimethylbiphenyl-3-yl)methyl)amino)phenyl)propanoic acidMeSH

  a GPR40 agonist; structure in first source

• C5764063-(2-hydroxy-1-methylethoxy)-N-(1-methyl-1H-pyrazol-3-yl)-5-(4-(methylsulfonyl)phenoxy)benzamideMeSH

  a glucokinase activator

• C5724913-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-olMeSH

  a synthetic cannabinoid; structure in first source

• C5776423-(2-mercaptoethyl)biphenyl-2,3-dicarboxylic acidMeSH

  inhibits glutamate carboxypeptidase II; structure in first source

• C5617433-(2-methoxy-1-methylethoxy)-5-(4-methylsulfonylphenoxy)-N-(3-methyl-1,2,4-thiadiazol-5-yl)benzamideMeSH

  a glucokinase activator

• C5710743-(2-methoxy-5-(1-(3,4,5-trimethoxyphenyl)vinyl)phenyl)prop-2-en-1-olMeSH

  has antineoplastic activity; structure in first source

• C5710753-(2-methoxy-5-(1-(3,4,5-trimethoxyphenyl)vinyl)phenyl)prop-2-yn-1-olMeSH

  has antineoplastic activity; structure in first source

• C5703503-(2-nitrophenyl)-1H-1,2,4-triazole-5(4H)-thioneMeSH

  a chelating ligand; structure in first source

• C5785243-(3'-adamantan-1-yl-4'-methoxybiphenyl-4-yl)-2-propenoic acidMeSH

  a comedolytic agent; structure in first source

• C5714463-(3'-quinolyl)-alanineMeSH

  structure in first source

• C5856133-(3,3-dichloro-2-hydroxylpropyl)-6-methoxy-8-O-beta-D-glucopyranosyl-1H-isochromen-1-oneMeSH

  from a cold-adapted fungal strain Mucor sp.; structure in first source

• C5729453-(3,4-dimethylphenyl)-1-(2-piperidin-1-ylethyl)piperidineMeSH

  structure in first source

• C5873323-(3,5-di-tert-butyl-4-fluorophenyl)propanoic acidMeSH

  from Streptomyces sp. TC1; structure in first source

• C5617073-(3,5-dibromo-4-(4-hydroxy-3-isopropyl-5-methylphenoxy)-2-methylphenylamino)-3-oxopropanoic acidMeSH

  a thyromimetic compound; structure in first source

• C5747643-(3-((2-(3,4-dimethoxyphenyl)ethyl)-methylamino)cyclohexyl)-7,8-dimethoxy-1,3,4,5-tetrahydrobenzo(d)azepin-2-oneMeSH

  structure in first source